Secreted immunomodulatory viral proteins as novel biotherapeutics

Alexandra Lucas, Douglas McFadden

Research output: Contribution to journalShort survey

70 Citations (Scopus)

Abstract

Many viruses have learned to evade or subvert the host antiviral immune responses by encoding and expressing immunomodulatory proteins that protect the virus from attack by elements of the innate and acquired immune systems. Some of these viral anti-immune regulators are expressed as secreted proteins that engage specific host immune targets in the extracellular environment, where they exhibit potent anti-immune properties. We review here viral immunomodulatory proteins that have been tested as anti-inflammatory reagents in animal models of disease caused by excessive inflammation or hyperactivated immune pathways. The potential for such viral molecules for the development of novel drugs to treat immune-based or inflammatory disorders is discussed.

Original languageEnglish (US)
Pages (from-to)4765-4774
Number of pages10
JournalJournal of Immunology
Volume173
Issue number8
DOIs
StatePublished - Oct 15 2004
Externally publishedYes

Fingerprint

Viral Proteins
Viruses
Animal Disease Models
Antiviral Agents
Immune System
Proteins
Anti-Inflammatory Agents
Inflammation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology

Cite this

Secreted immunomodulatory viral proteins as novel biotherapeutics. / Lucas, Alexandra; McFadden, Douglas.

In: Journal of Immunology, Vol. 173, No. 8, 15.10.2004, p. 4765-4774.

Research output: Contribution to journalShort survey

@article{301fdc40d5db44e5856a7515c7eb0395,
title = "Secreted immunomodulatory viral proteins as novel biotherapeutics",
abstract = "Many viruses have learned to evade or subvert the host antiviral immune responses by encoding and expressing immunomodulatory proteins that protect the virus from attack by elements of the innate and acquired immune systems. Some of these viral anti-immune regulators are expressed as secreted proteins that engage specific host immune targets in the extracellular environment, where they exhibit potent anti-immune properties. We review here viral immunomodulatory proteins that have been tested as anti-inflammatory reagents in animal models of disease caused by excessive inflammation or hyperactivated immune pathways. The potential for such viral molecules for the development of novel drugs to treat immune-based or inflammatory disorders is discussed.",
author = "Alexandra Lucas and Douglas McFadden",
year = "2004",
month = "10",
day = "15",
doi = "10.4049/jimmunol.173.8.4765",
language = "English (US)",
volume = "173",
pages = "4765--4774",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Secreted immunomodulatory viral proteins as novel biotherapeutics

AU - Lucas, Alexandra

AU - McFadden, Douglas

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Many viruses have learned to evade or subvert the host antiviral immune responses by encoding and expressing immunomodulatory proteins that protect the virus from attack by elements of the innate and acquired immune systems. Some of these viral anti-immune regulators are expressed as secreted proteins that engage specific host immune targets in the extracellular environment, where they exhibit potent anti-immune properties. We review here viral immunomodulatory proteins that have been tested as anti-inflammatory reagents in animal models of disease caused by excessive inflammation or hyperactivated immune pathways. The potential for such viral molecules for the development of novel drugs to treat immune-based or inflammatory disorders is discussed.

AB - Many viruses have learned to evade or subvert the host antiviral immune responses by encoding and expressing immunomodulatory proteins that protect the virus from attack by elements of the innate and acquired immune systems. Some of these viral anti-immune regulators are expressed as secreted proteins that engage specific host immune targets in the extracellular environment, where they exhibit potent anti-immune properties. We review here viral immunomodulatory proteins that have been tested as anti-inflammatory reagents in animal models of disease caused by excessive inflammation or hyperactivated immune pathways. The potential for such viral molecules for the development of novel drugs to treat immune-based or inflammatory disorders is discussed.

UR - http://www.scopus.com/inward/record.url?scp=6344227999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6344227999&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.173.8.4765

DO - 10.4049/jimmunol.173.8.4765

M3 - Short survey

C2 - 15470015

AN - SCOPUS:6344227999

VL - 173

SP - 4765

EP - 4774

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -